Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain, Intractable | 6 | 2024 | 179 | 3.390 |
Why?
|
| Stomatitis | 4 | 2022 | 193 | 2.570 |
Why?
|
| Methylene Blue | 4 | 2024 | 53 | 2.420 |
Why?
|
| Myofascial Pain Syndromes | 4 | 2019 | 9 | 2.290 |
Why?
|
| Pain Management | 7 | 2024 | 716 | 1.970 |
Why?
|
| Endocarditis | 3 | 2021 | 128 | 1.520 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2021 | 266 | 1.370 |
Why?
|
| Chronic Pain | 3 | 2024 | 262 | 1.310 |
Why?
|
| Analgesics | 7 | 2024 | 410 | 1.190 |
Why?
|
| Rectal Prolapse | 1 | 2024 | 7 | 0.960 |
Why?
|
| Echocardiography, Transesophageal | 6 | 2021 | 291 | 0.910 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2018 | 408 | 0.910 |
Why?
|
| Mouthwashes | 2 | 2021 | 42 | 0.880 |
Why?
|
| Opiate Alkaloids | 1 | 2022 | 5 | 0.850 |
Why?
|
| Metoclopramide | 2 | 2020 | 34 | 0.840 |
Why?
|
| Electric Stimulation Therapy | 1 | 2024 | 136 | 0.830 |
Why?
|
| Trigger Points | 2 | 2019 | 6 | 0.830 |
Why?
|
| Heart Valve Diseases | 3 | 2015 | 196 | 0.810 |
Why?
|
| Neuralgia | 2 | 2024 | 264 | 0.810 |
Why?
|
| Arthralgia | 2 | 2020 | 97 | 0.790 |
Why?
|
| Cancer Pain | 2 | 2024 | 344 | 0.790 |
Why?
|
| Pain Measurement | 4 | 2024 | 1017 | 0.760 |
Why?
|
| Sensory Thresholds | 2 | 2018 | 64 | 0.750 |
Why?
|
| Serotonin 5-HT4 Receptor Agonists | 1 | 2020 | 3 | 0.740 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 1 | 2020 | 5 | 0.740 |
Why?
|
| Post-Dural Puncture Headache | 1 | 2020 | 7 | 0.730 |
Why?
|
| Emergency Service, Hospital | 5 | 2015 | 1243 | 0.690 |
Why?
|
| Fractures, Spontaneous | 2 | 2014 | 87 | 0.680 |
Why?
|
| Sacroiliac Joint | 1 | 2019 | 20 | 0.670 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2020 | 131 | 0.670 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2019 | 14 | 0.660 |
Why?
|
| Cerebrovascular Disorders | 2 | 2021 | 158 | 0.640 |
Why?
|
| Pain | 2 | 2018 | 1698 | 0.630 |
Why?
|
| Low Back Pain | 1 | 2019 | 83 | 0.630 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 2 | 2009 | 17 | 0.610 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2015 | 66 | 0.600 |
Why?
|
| Anesthetics, Local | 1 | 2019 | 175 | 0.600 |
Why?
|
| Neoplasms | 8 | 2024 | 15914 | 0.590 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2019 | 235 | 0.580 |
Why?
|
| Adenosine | 1 | 2019 | 300 | 0.570 |
Why?
|
| Haloperidol | 1 | 2017 | 70 | 0.570 |
Why?
|
| Cordotomy | 1 | 2017 | 47 | 0.560 |
Why?
|
| Pain, Referred | 1 | 2016 | 3 | 0.550 |
Why?
|
| Gastroparesis | 1 | 2017 | 80 | 0.540 |
Why?
|
| Antiemetics | 1 | 2017 | 123 | 0.530 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2017 | 145 | 0.530 |
Why?
|
| Pain Perception | 1 | 2015 | 11 | 0.520 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 250 | 0.510 |
Why?
|
| Microcomputers | 1 | 2015 | 36 | 0.500 |
Why?
|
| Infusion Pumps | 1 | 2015 | 60 | 0.500 |
Why?
|
| Magnetic Fields | 1 | 2015 | 33 | 0.500 |
Why?
|
| Heart Valves | 1 | 2015 | 61 | 0.490 |
Why?
|
| Back Pain | 1 | 2015 | 63 | 0.490 |
Why?
|
| Bisphosphonate-Associated Osteonecrosis of the Jaw | 1 | 2014 | 13 | 0.490 |
Why?
|
| Mandibular Fractures | 1 | 2014 | 12 | 0.490 |
Why?
|
| Middle Aged | 23 | 2024 | 90457 | 0.470 |
Why?
|
| Adult | 23 | 2024 | 81993 | 0.470 |
Why?
|
| Aortic Diseases | 2 | 2011 | 194 | 0.460 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 327 | 0.460 |
Why?
|
| Phantom Limb | 1 | 2014 | 15 | 0.460 |
Why?
|
| Drug Contamination | 1 | 2014 | 52 | 0.460 |
Why?
|
| Phenytoin | 1 | 2014 | 84 | 0.450 |
Why?
|
| Tendinopathy | 1 | 2013 | 15 | 0.450 |
Why?
|
| Male | 29 | 2024 | 129081 | 0.450 |
Why?
|
| Humans | 45 | 2024 | 272039 | 0.450 |
Why?
|
| Intracranial Embolism | 1 | 2013 | 40 | 0.440 |
Why?
|
| Neck Pain | 1 | 2013 | 41 | 0.440 |
Why?
|
| Medical Errors | 1 | 2015 | 227 | 0.430 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 205 | 0.420 |
Why?
|
| Diphosphonates | 1 | 2014 | 264 | 0.420 |
Why?
|
| Migraine Disorders | 1 | 2013 | 85 | 0.410 |
Why?
|
| Catheterization, Central Venous | 1 | 2015 | 366 | 0.410 |
Why?
|
| Chest Pain | 1 | 2013 | 172 | 0.410 |
Why?
|
| Young Adult | 11 | 2024 | 22173 | 0.400 |
Why?
|
| Female | 25 | 2024 | 149291 | 0.390 |
Why?
|
| Cocaine-Related Disorders | 1 | 2014 | 239 | 0.380 |
Why?
|
| Analgesics, Opioid | 3 | 2019 | 1460 | 0.380 |
Why?
|
| Bone Marrow | 1 | 2019 | 2446 | 0.380 |
Why?
|
| Ulcer | 1 | 2011 | 80 | 0.370 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2013 | 441 | 0.340 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2011 | 155 | 0.340 |
Why?
|
| Vomiting | 2 | 2017 | 361 | 0.330 |
Why?
|
| Nephrectomy | 1 | 2014 | 808 | 0.320 |
Why?
|
| Emergency Medical Services | 2 | 2004 | 465 | 0.320 |
Why?
|
| Imidazoles | 1 | 2014 | 1061 | 0.310 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2021 | 7963 | 0.310 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2007 | 33 | 0.300 |
Why?
|
| Pericarditis | 1 | 2008 | 61 | 0.290 |
Why?
|
| Retrospective Studies | 10 | 2024 | 39828 | 0.270 |
Why?
|
| Palliative Care | 1 | 2017 | 2171 | 0.260 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 4138 | 0.250 |
Why?
|
| Autonomic Nerve Block | 1 | 2024 | 15 | 0.240 |
Why?
|
| Aged | 11 | 2024 | 73500 | 0.240 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 2070 | 0.240 |
Why?
|
| Double-Blind Method | 2 | 2022 | 2610 | 0.240 |
Why?
|
| Calcaneus | 1 | 2004 | 17 | 0.230 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2015 | 116 | 0.230 |
Why?
|
| Hypophosphatemia | 1 | 2004 | 27 | 0.230 |
Why?
|
| Administration, Topical | 1 | 2024 | 258 | 0.230 |
Why?
|
| Telangiectasis | 1 | 2023 | 21 | 0.230 |
Why?
|
| Micronutrients | 1 | 2024 | 75 | 0.220 |
Why?
|
| Pelvic Floor | 1 | 2022 | 44 | 0.210 |
Why?
|
| Pelvic Pain | 1 | 2022 | 47 | 0.210 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2008 | 523 | 0.200 |
Why?
|
| Diagnosis, Differential | 4 | 2015 | 4899 | 0.200 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 31071 | 0.200 |
Why?
|
| Single-Blind Method | 1 | 2022 | 406 | 0.190 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2021 | 32 | 0.190 |
Why?
|
| Malnutrition | 1 | 2004 | 225 | 0.180 |
Why?
|
| Alcoholism | 1 | 2004 | 330 | 0.180 |
Why?
|
| Sacroiliitis | 1 | 2020 | 4 | 0.180 |
Why?
|
| Radiography | 3 | 2017 | 1994 | 0.180 |
Why?
|
| Conservative Treatment | 1 | 2020 | 66 | 0.170 |
Why?
|
| Autoantibodies | 1 | 2023 | 600 | 0.170 |
Why?
|
| Esophageal Diseases | 1 | 2000 | 79 | 0.170 |
Why?
|
| Cohort Studies | 3 | 2022 | 9484 | 0.170 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 6208 | 0.160 |
Why?
|
| Edema | 1 | 2000 | 265 | 0.160 |
Why?
|
| Prevalence | 3 | 2015 | 3417 | 0.160 |
Why?
|
| Spondylitis, Ankylosing | 1 | 1998 | 38 | 0.160 |
Why?
|
| Face | 1 | 2000 | 251 | 0.160 |
Why?
|
| Aortic Valve Stenosis | 1 | 2023 | 403 | 0.160 |
Why?
|
| Treatment Outcome | 5 | 2024 | 33913 | 0.160 |
Why?
|
| Inflammation | 2 | 2021 | 2533 | 0.150 |
Why?
|
| Recurrence | 2 | 2019 | 4887 | 0.150 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 14651 | 0.150 |
Why?
|
| Visual Analog Scale | 1 | 2017 | 12 | 0.150 |
Why?
|
| Electrocardiography | 3 | 2013 | 1192 | 0.150 |
Why?
|
| Prospective Studies | 4 | 2016 | 13404 | 0.140 |
Why?
|
| Autistic Disorder | 1 | 2000 | 350 | 0.140 |
Why?
|
| Touch | 1 | 2017 | 70 | 0.140 |
Why?
|
| Ketamine | 1 | 2021 | 243 | 0.140 |
Why?
|
| Nerve Block | 1 | 2019 | 185 | 0.140 |
Why?
|
| Pain Threshold | 1 | 2017 | 133 | 0.140 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2017 | 48 | 0.140 |
Why?
|
| Follow-Up Studies | 5 | 2013 | 15273 | 0.140 |
Why?
|
| Quality of Life | 3 | 2021 | 4758 | 0.140 |
Why?
|
| Lumbar Vertebrae | 1 | 2017 | 250 | 0.130 |
Why?
|
| Brain | 1 | 2009 | 4257 | 0.130 |
Why?
|
| Erythromelalgia | 1 | 2015 | 3 | 0.130 |
Why?
|
| Torso | 1 | 2016 | 73 | 0.130 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2015 | 15 | 0.130 |
Why?
|
| Touch Perception | 1 | 2015 | 20 | 0.130 |
Why?
|
| Syndrome | 2 | 2014 | 1407 | 0.130 |
Why?
|
| Pelvis | 1 | 2017 | 384 | 0.130 |
Why?
|
| Nausea | 1 | 2017 | 540 | 0.130 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2015 | 121 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 1401 | 0.120 |
Why?
|
| Lower Extremity | 1 | 2017 | 284 | 0.120 |
Why?
|
| Spine | 1 | 2016 | 312 | 0.120 |
Why?
|
| Biosensing Techniques | 1 | 2015 | 82 | 0.120 |
Why?
|
| Abdominal Pain | 1 | 2017 | 379 | 0.120 |
Why?
|
| Central Venous Catheters | 1 | 2015 | 100 | 0.120 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2014 | 43 | 0.120 |
Why?
|
| Pyelonephritis | 1 | 2014 | 48 | 0.110 |
Why?
|
| Biological Assay | 1 | 2015 | 182 | 0.110 |
Why?
|
| Adolescent | 6 | 2016 | 32759 | 0.110 |
Why?
|
| Akathisia, Drug-Induced | 1 | 2013 | 15 | 0.110 |
Why?
|
| Retropharyngeal Abscess | 1 | 2013 | 11 | 0.110 |
Why?
|
| Amines | 1 | 2014 | 86 | 0.110 |
Why?
|
| Neck Muscles | 1 | 2013 | 33 | 0.110 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 629 | 0.110 |
Why?
|
| Pharyngitis | 1 | 2013 | 47 | 0.110 |
Why?
|
| Dopamine Antagonists | 1 | 2013 | 59 | 0.110 |
Why?
|
| Nitroglycerin | 1 | 2013 | 47 | 0.110 |
Why?
|
| Comorbidity | 1 | 2020 | 2428 | 0.110 |
Why?
|
| Mitral Valve | 1 | 2015 | 285 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 16252 | 0.110 |
Why?
|
| Intracranial Hemorrhages | 1 | 2013 | 120 | 0.100 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 286 | 0.100 |
Why?
|
| Drug Interactions | 1 | 2014 | 585 | 0.100 |
Why?
|
| Cocaine | 1 | 2014 | 244 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2013 | 316 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2024 | 2672 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 2365 | 0.100 |
Why?
|
| Thoracic Wall | 1 | 2013 | 188 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 4512 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2013 | 835 | 0.090 |
Why?
|
| Neck | 1 | 2013 | 392 | 0.090 |
Why?
|
| Time Factors | 3 | 2015 | 13135 | 0.090 |
Why?
|
| Emergency Treatment | 1 | 2011 | 105 | 0.090 |
Why?
|
| Risk Factors | 3 | 2015 | 18024 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2015 | 1049 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2013 | 534 | 0.080 |
Why?
|
| Prognosis | 3 | 2015 | 22543 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 4398 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 7792 | 0.080 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 943 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 5330 | 0.070 |
Why?
|
| Leg | 1 | 2007 | 216 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 4993 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 9050 | 0.060 |
Why?
|
| Registries | 1 | 2013 | 2247 | 0.060 |
Why?
|
| Incidence | 1 | 2015 | 5859 | 0.060 |
Why?
|
| Osteomalacia | 1 | 2004 | 36 | 0.060 |
Why?
|
| Phosphorus | 1 | 2004 | 70 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 995 | 0.060 |
Why?
|
| Syncope | 1 | 2023 | 61 | 0.060 |
Why?
|
| Tongue | 1 | 2023 | 85 | 0.060 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 2287 | 0.050 |
Why?
|
| Diuretics | 1 | 2004 | 173 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2015 | 6882 | 0.050 |
Why?
|
| Parenteral Nutrition | 1 | 2004 | 212 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2004 | 177 | 0.050 |
Why?
|
| Echocardiography | 1 | 2008 | 1238 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2015 | 6233 | 0.050 |
Why?
|
| Osteomyelitis | 1 | 2004 | 260 | 0.050 |
Why?
|
| Rupture, Spontaneous | 1 | 2000 | 69 | 0.050 |
Why?
|
| Mediastinal Emphysema | 1 | 2000 | 14 | 0.050 |
Why?
|
| Esophagoscopy | 1 | 2000 | 310 | 0.040 |
Why?
|
| Logistic Models | 1 | 2006 | 3464 | 0.040 |
Why?
|
| United States | 1 | 2014 | 16033 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 130 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2015 | 159 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 230 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 434 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 531 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 434 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 1101 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 3179 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2015 | 642 | 0.020 |
Why?
|
| Child | 1 | 2009 | 30577 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2015 | 2251 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 1300 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 5519 | 0.020 |
Why?
|
| Survival Rate | 1 | 1998 | 12547 | 0.020 |
Why?
|